30 results match your criteria: "Vesia (Alberta Bladder Centre)[Affiliation]"
Obstet Gynecol
November 2022
Department of Surgery, University of Alberta Faculty of Medicine and Dentistry, Edmonton, and the Department of Surgery and the Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, and Vesia [Alberta Bladder Centre], Southern Alberta Institute of Urology, Calgary, Alberta, Canada.
Objective: To describe the etiology and presenting symptoms of periurethral and anterior vaginal wall masses in a large series of patients in an academic institution.
Methods: A retrospective chart review of 126 patients presenting and undergoing treatment for periurethral and anterior vaginal wall masses between November 2001 and July 2021 was completed. Clinicopathologic data were extracted.
Can Urol Assoc J
July 2022
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Can Urol Assoc J
January 2022
Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Can Urol Assoc J
December 2021
vesia [Alberta Bladder Centre], Calgary, AB, Canada.
Introduction: This study aimed to describe the effects of bladder function following radiotherapy for localized prostate cancer by performing a systematic review on studies reporting on urodynamic findings after radiotherapy.
Methods: This systematic review was conducted in accordance with PRISMA guidelines. The review protocol was registered at PROSPERO (CRD42021229037).
Int Urogynecol J
September 2021
Division of Urology, Department of Surgery, Southern Alberta Institute of Urology, University of Calgary, Calgary, Alberta, Canada.
Introduction And Hypothesis: To highlight the success rates of two approaches of transvaginal vs. transabdominal closures for the vesicovaginal fistula (VVF) repair and to investigate the patient, fistula, and surgical factors relevant to surgical characteristics and successful outcomes.
Methods: Retrospective analysis of 66 consecutive patients who underwent VVF repair between 2005 and 2020.
Neurourol Urodyn
February 2021
Vesia (Alberta Bladder Centre), Southern Alberta Institute of Urology, Calgary, Alberta, Canada.
Aims: This study aims to describe the effects of radical prostatectomy (RP) on bladder function by performing a systematic review of urodynamics study findings before and after RP.
Methods: This systematic review was conducted in accordance with the PRISMA guideline and registered on PROSPERO (CRD42020206844). A systematic search was conducted using PubMed, Cochrane, and Embase.
Transl Androl Urol
October 2020
Vesia (Alberta Bladder Centre), Calgary, Alberta, Canada.
Background: Research on prostate cancer survivorship patients has largely been on oncological outcome, incontinence and erectile dysfunction, with less data on the relationship between prostate cancer, bladder function and mental health. This study aims to elucidate the prevalence of lower urinary tract symptoms (LUTS), overactive bladder (OAB), sexual dysfunction, depression and anxiety in Canadian men with newly diagnosed localised prostate cancer.
Methods: This is a single-centre prospective cross-sectional study of men with newly diagnosed localized prostate cancer recruited from June 2017 to July 2018.
BJU Int
February 2021
Division of Urology, Department of Surgery, University of Calgary, Calgary, AB, Canada.
Objectives: To evaluate the incidence and predictors of hospital readmission and emergency department (ED) visits in patients with benign prostatic hyperplasia treated by transurethral resection of the prostate (TURP).
Patients And Methods: We conducted a retrospective cohort study using a linked administrative dataset from Calgary, Canada. Participants were men who underwent their first TURP procedure between 2015 and 2017.
Can Urol Assoc J
July 2020
Division of Urology, Department of Surgery, University of Western Ontario, London, ON, Canada.
We determined whether the patient-reported benefits of physiotherapy for stress urinary incontinence (SUI) symptoms differ significantly between men who have had open prostatectomy and those who have had robotic-assisted laparoscopic prostatectomy. We conducted a retrospective analysis of data collected from the Rapid Access Clinic 4 offered by the Prostate Cancer Centre in Calgary, Alberta. Baseline characteristics were measured at the pre-surgery appointment, including demographics, health factors, and potential risk factors for SUI.
View Article and Find Full Text PDFCan Urol Assoc J
April 2020
Department of Surgery, University of Calgary, Calgary, AB, Canada.
Introduction: We aimed to evaluate the psychometric properties of the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) for measuring the quality of life in patients treated for localized prostate cancer. The EPIC-26 is a patient-reported outcome instrument recommended for use with patients treated for localized prostate cancer.
Methods: This study is based on data collected prospectively between September 2014 and February 2017 in Alberta, Canada.
Urology
March 2019
Department of Surgery, University of Calgary, Calgary, Alberta, Canada; VESIA [Alberta Bladder Centre], Calgary, Alberta, Canada.
Objectives: To develop a statistical model to facilitate the comparison of 2 common patient-reported outcome (PRO) instruments in male lower urinary tract symptoms.
Methods: Two PROs used by urologists are the International Prostate Symptoms Severity (IPSS) and the Overactive Bladder-Validated 8 questions (OAB-V8). The former measures symptoms related to prostate cancer, the latter measures the severity of symptoms related to OAB.
Can Urol Assoc J
June 2019
vesia [Alberta Bladder Centre], Calgary, AB, Canada.
Introduction: Lower urinary tract symptoms (LUTS) are being treated in secondary care settings, resulting in delayed access for all patients. The objectives of this study were to examine the effects of an integrated delivery model on 1) the volume of care delivered in the secondary care setting; and 2) the use of potentially unnecessary care associated with LUTS.
Methods: This study was based on a retrospective analysis of administrative data collected before and after the integrated LUTS clinic was introduced in Calgary, Alberta.
Can Urol Assoc J
October 2018
Vesia [Alberta Bladder Centre]; Division of Urology, Department of Surgery, University of Calgary, Calgary AB, Canada.
Can Urol Assoc J
May 2018
Vesia [Alberta Bladder Centre]; Division of Urology, Department of Surgery, University of Calgary, Calgary AB; Canada.
J Spinal Cord Med
July 2020
Vesia [Alberta Bladder Centre], Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
Autonomic dysreflexia is a potentially lethal condition experienced by spinal cord injury (SCI) patients. It has a wide range of causes, most of which are genitourinary in nature. However, there has been no documented case of primary bladder cancer as a trigger for recurrent autonomic dysreflexia.
View Article and Find Full Text PDFNeurourol Urodyn
March 2018
Vesia [Alberta Bladder Centre], Calgary, Alberta, Canada.
Aims: The OAB-v8 is a patient-reported outcome questionnaire used to screen for overactive bladder and measure symptom bother. This study uses modern validation methods to assess the item and test characteristics of the OAB-v8, and determine whether it should be scored differently for men and women.
Methods: A secondary analysis of data from patients with lower urinary tract symptoms prospectively recruited from a urology clinic in Calgary, Canada.
Can Urol Assoc J
June 2017
Section of Urology, Department of Surgery, University of Calgary, Calgary, AB; Canada.
Midurethral slings (MUS) are a proven effective treatment option for stress urinary incontinence (SUI) and have become the gold standard in most centres in North America. MUS implantation can be associated with risks that are common to all anti-incontinence surgeries, and others which are unique. This article reviews the intraoperative and the early and late postoperative risks associated with these procedures, with insights into their prevention, diagnosis, and management drawn from the literature and expert opinion.
View Article and Find Full Text PDFCan Urol Assoc J
June 2017
vesia [Alberta Bladder Centre] and Department of Surgery, University of Calgary, Calgary, AB; Canada.
Mixed urinary incontinence is a common diagnosis among women with urinary leakage and is often present in women who are unable to characterize their incontinence. Research and optimized clinical treatment of these patients is limited by the challenges in objectively defining and stratifying this population. The evaluation of these patients should follow the same general principles as any assessment of any women with incontinence; however, it is essential to define whether urge or stress incontinence is the predominant symptom.
View Article and Find Full Text PDFCan Urol Assoc J
June 2017
vesia [Alberta Bladder Centre] and Department of Surgery, University of Calgary, Calgary, AB; Canada.
In recent years, midurethral slings (MUS) and transvaginal mesh procedures have experienced blazing growth and popularity. However, the US Food and Drug Administration (FDA) and Health Canada regulatory advisories threw water on that fire and created a confusing environment surrounding their continued usage. MUS usage has continued in Canada and transvaginal mesh kits for pelvic organ prolapse have become a rarity.
View Article and Find Full Text PDFCan Urol Assoc J
June 2017
Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON; Canada.
Stress incontinence (SUI) and pelvic organ prolapse (POP) are common conditions. There is high-level evidence that midurethral mesh slings for stress incontinence are effective and safe; however, the rare but serious potential risks of this surgery must be discussed with the patient. The use of transvaginal mesh for prolapse repair does not appear to be supported by the current evidence, and its use should be restricted to specialized pelvic floor surgeons and specific clinical situations.
View Article and Find Full Text PDFCan Urol Assoc J
May 2017
vesia [Alberta Bladder Centre], University of Calgary, Calgary, AB, Canada.
Introduction: The objective of this study was to compare efficacy and safety outcomes between patients receiving onabotulinum-toxinA (OnabotA) for the first time and those receiving a repeat injection.
Methods: Data collected before and after OnabotA injection were extracted from a clinical registry. Patients were classified into either first or repeat injection subgroups.
Can Urol Assoc J
January 2017
vesia [Alberta Bladder Centre] and Department of Surgery, University of Calgary, Calgary, AB, Canada.
While arteriovenous malformations (AVMs) are a common congenital or post-traumatic abnormality, male genital AVMs are rare and have been described in the scrotum or penis in pediatric patients.1,2 We describe a 34-year-old male presenting with recurrent spontaneous penile urethral bleeding found to have an AVM of the penile urethra. While angiography has traditionally been helpful, magnetic resonance imaging (MRI) can aid in the diagnosis and characterization of these lesions.
View Article and Find Full Text PDF